Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Finasteride safely lowers DHT levels without affecting testosterone.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Alpha1-blockers effectively improve urinary symptoms in BPH, with alfuzosin and tamsulosin having fewer side effects.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

Finasteride does not negatively affect male reproductive function.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

5-alpha reductase inhibitors help with benign prostatic hyperplasia but don't cure it, and more research is needed.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Dutasteride works better than finasteride for hair growth with similar side effects.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Long-term finasteride use may lower prostate cancer risk but increase the need for erectile dysfunction medication.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

5ARI treatment improves hair growth in older men with minimal side effects.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.